Legal & General Group’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-1,370
| Closed | -$25K | – | 3534 |
|
|
2020
Q4 | $25K | Hold |
1,370
| – | – | ﹤0.01% | 3011 |
|
|
2020
Q3 | $25K | Sell |
1,370
-506
| -27% | -$9.23K | ﹤0.01% | 2920 |
|
|
2020
Q2 | $28K | Sell |
1,876
-68
| -3% | -$1.02K | ﹤0.01% | 2930 |
|
|
2020
Q1 | $30K | Sell |
1,944
-685
| -26% | -$10.6K | ﹤0.01% | 2769 |
|
|
2019
Q4 | $43K | Buy |
2,629
+351
| +15% | +$5.74K | ﹤0.01% | 2872 |
|
|
2019
Q3 | $34K | Hold |
2,278
| – | – | ﹤0.01% | 2910 |
|
|
2019
Q2 | $34K | Buy |
2,278
+550
| +32% | +$8.21K | ﹤0.01% | 2957 |
|
|
2019
Q1 | $30K | Hold |
1,728
| – | – | ﹤0.01% | 2935 |
|
|
2018
Q4 | $31K | Hold |
1,728
| – | – | ﹤0.01% | 2898 |
|
|
2018
Q3 | $31K | Hold |
1,728
| – | – | ﹤0.01% | 3014 |
|
|
2018
Q2 | $34K | Buy |
+1,728
| New | +$34K | ﹤0.01% | 2961 |
|
|
2017
Q2 | – | Sell |
-3,076
| Closed | -$37K | – | 3409 |
|
|
2017
Q1 | $37K | Sell |
3,076
-1,000
| -25% | -$12K | ﹤0.01% | 2929 |
|
|
2016
Q4 | $54K | Buy |
4,076
+1,884
| +86% | +$25K | ﹤0.01% | 2872 |
|
|
2016
Q3 | $31K | Hold |
2,192
| – | – | ﹤0.01% | 2724 |
|
|
2016
Q2 | $25K | Buy |
+2,192
| New | +$25K | ﹤0.01% | 2804 |
|